By Admin at 23 Aug 2016
A new chemotherapy drug has shown promise for treating both childhood and adult cancers with improvements above-and-beyond typical chemotherapy treatment. The treatment involves a novel class of antitumor amphiphilic amines (RCn).
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial
